UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 18, 2021
Blue Whale Acquisition Corp I
(Exact name of registrant as specified in its charter)
Cayman Islands | 001-40706 | 98-1590107 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
PO Box 1093, Boundary Hall, Cricket Square, Grand Caymans Cayman Islands |
KY1-1102 | |
(Address of principal executive offices) | (Zip Code) |
+1 (345) 949-8066
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant | BWCAU | The Nasdaq Stock Market LLC | ||
Class A common stock, par value $0.0001 per share | BWC | The Nasdaq Stock Market LLC | ||
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 | BWCAW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 | Other Events. |
As previously reported on a Current Report on Form 8-K of Blue Whale Acquisition Corp I (the Company), on August 13, 2021, the Company consummated its initial public offering (the IPO) of 20,000,000 units (the Units). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an Ordinary Share), and one-fourth of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000. The Company granted the underwriters of the IPO (the Underwriters) a 45-day option to purchase up to an additional 3,000,000 units at the IPO price to cover over-allotments, if any. On August 16, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,940,811 Units from the Company (the Over-Allotment Units), generating gross proceeds of $29,408,110 and resulting in the issuance of an additional 326,757 Class F ordinary shares and 653,513 Class G ordinary shares to the Companys sponsor, Blue Whale Sponsor I LLC (the Sponsor).
As previously reported on a Current Report on Form 8-K of the Company, substantially concurrently with the closing of the IPO, the Company completed the private sale of 3,000,000 warrants (the Private Placement Warrants) at a purchase price of $2.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $6,000,000. In connection with the Underwriters partial exercise of their over-allotment option, the Sponsor purchased an additional 294,081 Private Placement Warrants (the Additional Private Placement Warrants), generating gross proceeds to the Company of approximately $588,162.20.
In connection with the closing and sale of the Over-Allotment Units and the Additional Private Placement Warrants (together, the Over-Allotment Closing), a total of $29,408,110 in proceeds from the Over-Allotment Closing (which amount includes $1,029,283.85 of the Underwriters deferred discount) was placed in a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee.
An audited balance sheet as of August 6, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the sale of the Private Placement Warrants has been issued by the Company and previously filed as Exhibit 99.1 to a Current Report on Form 8-K on August 13, 2021. The Companys unaudited pro forma balance sheet as of August 6, 2021, adjusted for the Over-Allotment Closing on August 18, 2021 is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits. The following exhibits are filed with this Form 8-K:
Exhibit No. | Description of Exhibits | |
99.1 | Unaudited Pro Forma Balance Sheet as of August 6, 2021. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Blue Whale Acquisition Corp I | ||||||
Date: August 24, 2021 | By: | /s/ Maxime Franzetti | ||||
Name: Maxime Franzetti | ||||||
Title: Chief Executive Officer |
Exhibit 99.1
BLUE WHALE ACQUISITION CORP I
UNAUDITED PRO FORMA BALANCE SHEET AS OF AUGUST 6, 2021
August 6, 2021 | Pro Forma Adjustments |
As Adjusted | ||||||||||||
(unaudited) | (unaudited) | |||||||||||||
ASSETS |
||||||||||||||
Cash |
$ | 2,000,491 | $ | | $ | 2,000,491 | ||||||||
Prepaid Expense |
19,200 | | 19,200 | |||||||||||
|
|
|
|
|
|
|||||||||
Total current assets |
2,019,691 | | 2,019,691 | |||||||||||
Cash held in Trust Account |
200,000,000 | 29,408,110 | (a) | 229,408,110 | ||||||||||
588,162 | (b) | |||||||||||||
(588,162 | ) | (c) | ||||||||||||
|
|
|
|
|
|
|||||||||
Total Assets |
$ | 202,019,691 | $ | 29,408,110 | 231,427,801 | |||||||||
|
|
|
|
|
|
|||||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||||||||
Current Liabilities |
||||||||||||||
Accounts payablerelated party |
481,384 | | 481,384 | |||||||||||
Accrued expenses |
682,821 | | 682,821 | |||||||||||
|
|
|
|
|
|
|||||||||
Total Current Liabilities |
1,164,205 | | 1,164,205 | |||||||||||
Warrant Liability |
8,560,000 | | 8,560,000 | |||||||||||
FPA Liability |
100,000 | | 100,000 | |||||||||||
Deferred underwriting fee payable |
7,000,000 | 1,029,284 | (d) | 8,029,284 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Liabilities |
16,824,205 | 1,029,284 | 17,853,489 | |||||||||||
|
|
|
|
|
|
|||||||||
Commitments and Contingencies (Note 6) |
||||||||||||||
Class A ordinary shares subject to possible redemption, 18,019,548 and 20,857,431 at redemption value, respectively |
180,195,480 | 28,378,830 | (e) | 208,574,310 | ||||||||||
Shareholders Equity |
||||||||||||||
Preference shares$0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |
| | | |||||||||||
Class A ordinary shares$0.0001 par value; 200,000,000 shares authorized; 1,980,452 and 2,083,380 issued and outstanding, respectively |
198 | 294 | (a) | 208 | ||||||||||
(284 | ) | (e) | ||||||||||||
Class F ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 2,222,222 and 2,548,979 shares issued and outstanding, respectively |
222 | 33 | (f) | 255 | ||||||||||
Class G ordinary shares, $0.0001 par value; 30,000,000 shares authorized, 4,444,445 and 5,097,958 shares issued and outstanding, respectively |
444 | 65 | (f) | 509 | ||||||||||
Additional paid-in capital |
5,346,782 | 29,407,816 | (a) | 5,346,670 | ||||||||||
588,162 | (b) | |||||||||||||
(588,162 | ) | (c) | ||||||||||||
(1,029,284 | ) | (d) | ||||||||||||
(28,378,546 | ) | (e) | ||||||||||||
(98 | ) | (f) | ||||||||||||
Accumulated Deficit |
(347,640 | ) | | (347,640 | ) | |||||||||
|
|
|
|
|
|
|||||||||
Total Shareholders Equity |
5,000,006 | (4 | ) | 5,000,002 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Liabilities and Stockholders Equity |
202,019,691 | $ | 29,408,110 | $ | 231,427,801 | |||||||||
|
|
|
|
|
|
The accompany notes are an integral part of the financial statement.
NOTE 1CLOSING OF OVER-ALLOTMENT OPTION AND ADDITIONAL PRIVATE PLACEMENT
The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of Blue Whale Acquisition Corp I. (the Company) as of August 6, 2021, adjusted for the closing of the underwriters over-allotment option and related transactions which occurred on August 16, 2021 as described below.
The Company consummated its initial public offering (the IPO) of 20,000,000 units (the Units). Each Unit consists of one Class A ordinary share, $0.0001 par value per share and one-fourth of one redeemable warrant to purchase one Class A ordinary share. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000. The Company granted the underwriters in the IPO (the Underwriters) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, if any. On August 16, 2021, the Underwriters partially exercised the over-allotment option and purchased an additional 2,940,811 Over-Allotment Units, generating an aggregate of gross proceeds of $29,480,110, incurred $588,162 in cash underwriting fees, and forfeited the remainder of the option, which over-allotment closed on August 18, 2021.
Simultaneously with the closing of the exercise of the overallotment option, the Company completed the private sale (the Private Placement) of an aggregate of 294,081 Private Warrants (the Private Placement Warrants) to the Companys Sponsor, Blue Whale Sponsor I LLC, at a purchase price of $2.00 per Private Warrant, generating gross proceeds of $588,162.
Upon closing of the IPO, the Private Placement, and the sale of the Over-Allotment Units, a total of $229,408,110 ($10.00 per Unit) was placed in a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee.
Pro forma adjustments to reflect the exercise of the Underwriters over-allotment option, the sale of the Private Warrants, and the issuance of Class F and G ordinary shares are as follows:
Pro Forma Entries | Debit | Credit | ||||||
(a) Cash held in trust |
$ | 29,408,110 | ||||||
Class A ordinary shares |
$ | 294 | ||||||
Additional paid-in capital |
$ | 29,407,816 | ||||||
To record sale of 2,940,811 Overallotment Units at $10.00 per Unit |
| |||||||
(b) Cash held in trust |
$ | 588,162 | ||||||
Additional paid-in capital |
$ | 588,162 | ||||||
To record sale of 294,081 Private Warrants at $2.00 per Private Warrant |
| |||||||
(c) Additional paid-in capital |
$ | 588,162 | ||||||
Cash held in trust |
$ | 588,162 | ||||||
To record payment of cash underwriting fee |
| |||||||
(d) Additional paid-in capital |
$ | 1,029,284 | ||||||
Deferred underwriting fee payable |
$ | 1,029,284 | ||||||
To record additional Deferred underwriters fee arising from the sale of Overallotment Units |
| |||||||
(e) Class A ordinary shares |
$ | 284 | ||||||
Additional paid-in capital |
$ | 28,378,546 | ||||||
Class A ordinary shares subject to possible redemption |
$ | 28,378,830 | ||||||
To record Class A ordinary shares out of permanent equity into mezzanine redeemable shares |
| |||||||
(f) Additional paid-in capital |
$ | 98 | ||||||
Class F ordinary shares |
$ | 33 | ||||||
Class G ordinary shares |
$ | 65 | ||||||
To record the additional Class F and Class G ordinary shares issued as a result of the partial exercise |
|